Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection

Hepatitis C virus (HCV) infection is a global medical problem. The current standard of treatment consists of the combination of peginterferon plus ribavirin. This regimen eradicates HCV in 55% of cases. The immune response to HCV is an important determinant of disease evolution and can be influenced by various host factors. HLA class II may play an important role in immune response against HCV. The objective of the present study was to determine the distribution of HLA class II (DRB1 and DQB1) alleles, their association with chronic HCV infection and their response to interferon therapy. One hundred and two unrelated white Brazilian patients with chronic HCV infection, 52 responders (45 males and 7 females) and 50 non-responders (43 males and 7 females) to antiviral treatment, were included in the study. Healthy Brazilian bone marrow donors of Caucasian origin from the same geographic area constituted the control group (HLA-DRB1, N = 99 and HLA-DQB1, N = 222 individuals). HLA class II genotyping was performed using a low-resolution DRB1, DQB1 sequence-specific primer amplification. There were higher frequencies of HLA-DRB1*13 (26.5 vs 14.1%) and HLA-DQB1*02 (52.9 vs 38.7%) in patients compared with controls; however, these were not significantly different after P correction (Pc = 0.39 and Pc = 0.082, respectively). There was no significant difference between the phenotypic frequencies of HLA-DRB1 (17.3 vs 14.0%) and HLA-DQB1 alleles in responder and non-responder HCV patients. The HLA-DRB1*07 allele was significantly more common in HCV patients (33.3 vs 12.1%) than in controls (Pc = 0.0039), suggesting that the HLA-DRB1*07 allele is associated with chronic HCV infection.

Saved in:
Bibliographic Details
Main Authors: Corghi,D.B., Gonçales,N.S.L., Marques,S.B.D., Gonçales Jr.,F.L.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001000009
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2008001000009
record_format ojs
spelling oai:scielo:S0100-879X20080010000092009-01-13Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infectionCorghi,D.B.Gonçales,N.S.L.Marques,S.B.D.Gonçales Jr.,F.L. HLA class II HLA DR/DQ HLA genotyping PCR Hepatitis C virus Chronic hepatitis C Interferon treatment Hepatitis C virus (HCV) infection is a global medical problem. The current standard of treatment consists of the combination of peginterferon plus ribavirin. This regimen eradicates HCV in 55% of cases. The immune response to HCV is an important determinant of disease evolution and can be influenced by various host factors. HLA class II may play an important role in immune response against HCV. The objective of the present study was to determine the distribution of HLA class II (DRB1 and DQB1) alleles, their association with chronic HCV infection and their response to interferon therapy. One hundred and two unrelated white Brazilian patients with chronic HCV infection, 52 responders (45 males and 7 females) and 50 non-responders (43 males and 7 females) to antiviral treatment, were included in the study. Healthy Brazilian bone marrow donors of Caucasian origin from the same geographic area constituted the control group (HLA-DRB1, N = 99 and HLA-DQB1, N = 222 individuals). HLA class II genotyping was performed using a low-resolution DRB1, DQB1 sequence-specific primer amplification. There were higher frequencies of HLA-DRB1*13 (26.5 vs 14.1%) and HLA-DQB1*02 (52.9 vs 38.7%) in patients compared with controls; however, these were not significantly different after P correction (Pc = 0.39 and Pc = 0.082, respectively). There was no significant difference between the phenotypic frequencies of HLA-DRB1 (17.3 vs 14.0%) and HLA-DQB1 alleles in responder and non-responder HCV patients. The HLA-DRB1*07 allele was significantly more common in HCV patients (33.3 vs 12.1%) than in controls (Pc = 0.0039), suggesting that the HLA-DRB1*07 allele is associated with chronic HCV infection.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.41 n.10 20082008-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001000009en10.1590/S0100-879X2008005000041
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Corghi,D.B.
Gonçales,N.S.L.
Marques,S.B.D.
Gonçales Jr.,F.L.
spellingShingle Corghi,D.B.
Gonçales,N.S.L.
Marques,S.B.D.
Gonçales Jr.,F.L.
Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
author_facet Corghi,D.B.
Gonçales,N.S.L.
Marques,S.B.D.
Gonçales Jr.,F.L.
author_sort Corghi,D.B.
title Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
title_short Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
title_full Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
title_fullStr Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
title_full_unstemmed Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection
title_sort distribution of the human leukocyte antigen class ii alleles in brazilian patients with chronic hepatitis c virus infection
description Hepatitis C virus (HCV) infection is a global medical problem. The current standard of treatment consists of the combination of peginterferon plus ribavirin. This regimen eradicates HCV in 55% of cases. The immune response to HCV is an important determinant of disease evolution and can be influenced by various host factors. HLA class II may play an important role in immune response against HCV. The objective of the present study was to determine the distribution of HLA class II (DRB1 and DQB1) alleles, their association with chronic HCV infection and their response to interferon therapy. One hundred and two unrelated white Brazilian patients with chronic HCV infection, 52 responders (45 males and 7 females) and 50 non-responders (43 males and 7 females) to antiviral treatment, were included in the study. Healthy Brazilian bone marrow donors of Caucasian origin from the same geographic area constituted the control group (HLA-DRB1, N = 99 and HLA-DQB1, N = 222 individuals). HLA class II genotyping was performed using a low-resolution DRB1, DQB1 sequence-specific primer amplification. There were higher frequencies of HLA-DRB1*13 (26.5 vs 14.1%) and HLA-DQB1*02 (52.9 vs 38.7%) in patients compared with controls; however, these were not significantly different after P correction (Pc = 0.39 and Pc = 0.082, respectively). There was no significant difference between the phenotypic frequencies of HLA-DRB1 (17.3 vs 14.0%) and HLA-DQB1 alleles in responder and non-responder HCV patients. The HLA-DRB1*07 allele was significantly more common in HCV patients (33.3 vs 12.1%) than in controls (Pc = 0.0039), suggesting that the HLA-DRB1*07 allele is associated with chronic HCV infection.
publisher Associação Brasileira de Divulgação Científica
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001000009
work_keys_str_mv AT corghidb distributionofthehumanleukocyteantigenclassiiallelesinbrazilianpatientswithchronichepatitiscvirusinfection
AT goncalesnsl distributionofthehumanleukocyteantigenclassiiallelesinbrazilianpatientswithchronichepatitiscvirusinfection
AT marquessbd distributionofthehumanleukocyteantigenclassiiallelesinbrazilianpatientswithchronichepatitiscvirusinfection
AT goncalesjrfl distributionofthehumanleukocyteantigenclassiiallelesinbrazilianpatientswithchronichepatitiscvirusinfection
_version_ 1756391239894171648